Agency Information Collection Activities: Submission for OMB Review; Comment Request, 37589-37590 [E6-10286]
Download as PDF
<![CDATA[
37589
Federal Register / Vol. 71, No. 126 / Friday, June 30, 2006 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Eva Petrakova, PhD, MPH
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892. 301–435–
1716. petrakoe@mail.nih.gov
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Nutrition
Literacy.
Date: July 10, 2006.
Time: 10:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Lee S. Mann, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7848, Bethesda, MD 20892. 301–435–
0677. mannl@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; HOP EPI.
Date: July 13, 2006.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: One Washington Circle Hotel, One
Washington Circle, Washington, DC 20037.
Contact Person: Heidi B. Friedman, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1012A,
MSC 7770, Bethesda, MD 20892. 301–435–
1721. hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; IRAP
Member Conflicts.
Date: July 14, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: One Washington Circle Hotel, One
Washington Circle, Washington, DC 20037.
Contact Person: Heidi B. Friedman, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1012A,
MSC 7770, Bethesda, MD 20892. 301–435–
1721. hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Emotion
Stress and Decision Making.
Date: July 19, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Victoria S. Levin, MSW,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3172,
MSC 7848, Bethesda, MD 20892. 301–435–
0912. levin@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Proposed Project: Mandatory
Guidelines for Federal Workplace Drug
Testing Programs (OMB No. 0930–
0158)—Revision
Dated: June 22, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5886 Filed 6–29–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
SAMHSA’s Mandatory Guidelines for
Federal Workplace Drug Testing
Programs will request OMB approval for
the Federal Drug Testing Custody and
Control Form for Federal agency and
federally regulated drug testing
programs which must comply with the
HHS Mandatory Guidelines for Federal
Workplace Drug Testing Programs (69
FR 19644) dated April 13, 2004, and for
the information provided by laboratories
for the National Laboratory Certification
Program (NLCP).
The Federal Drug Testing Custody
and Control Form is used by all Federal
agencies and employers regulated by the
Department of Transportation to
document the collection and chain of
custody of urine specimens at the
collection site, for laboratories to report
results, and for Medical Review Officers
to make a determination. The Federal
Drug Testing Custody and Control Form
approved by OMB three years ago is
being resubmitted for OMB approval
without any revision.
Prior to an inspection, a laboratory is
required to submit specific information
regarding its laboratory procedures.
Collecting this information prior to an
inspection allows the inspectors to
thoroughly review and understand the
laboratory(s testing procedures before
arriving at the laboratory.
The NLCP application form has not
been revised compared to the previous
form.
The annual total burden estimates for
the Federal Drug Testing Custody and
Control Form, the NLCP application, the
NLCP inspection checklist, and NLCP
recordkeeping requirements are shown
in the following table.
Burden/
response
(Hrs.)
Form/respondent
rwilkins on PROD1PC63 with NOTICES_1
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Number of
responses
Total annual
burden
(Hrs.)
Custody and Control Form
Donor ....................................................................................................................................
Collector ................................................................................................................................
Laboratory .............................................................................................................................
Medical Review Officer .........................................................................................................
Laboratory Application .................................................................................................................
Laboratory Inspection Checklist ..................................................................................................
Laboratory Recordkeeping ..........................................................................................................
.08
.07
.05
.05
3.00
3.00
250.00
7,096,000
7,096,000
7,096,000
7,096,000
3
100
50
567,680
496,720
354,800
354,800
9
300
12,500
Total ......................................................................................................................................
........................
........................
1,786,809
VerDate Aug<31>2005
16:30 Jun 29, 2006
Jkt 208001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
E:\FR\FM\30JNN1.SGM
30JNN1
37590
Federal Register / Vol. 71, No. 126 / Friday, June 30, 2006 / Notices
Written comments and
recommendations concerning the
proposed information collection should
be sent by July 31, 2006 to: SAMHSA
Desk Officer, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503; due to potential delays in OMB’s
receipt and processing of mail sent
through the U.S. Postal Service,
respondents are encouraged to submit
comments by fax to: 202–395–6974.
Dated: June 26, 2006.
Anna Marsh,
Director, Office of Program Services.
[FR Doc. E6–10286 Filed 6–29–06; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
rwilkins on PROD1PC63 with NOTICES_1
Notice Regarding Substance Abuse
and Mental Health Services
Administration’s National Registry of
Evidence-Based Programs and
Practices (NREPP): Priorities for
NREPP Reviews
Summary: The Substance Abuse and
Mental Health Services Administration
(SAMHSA) is committed to preventing
the onset and reducing the progression
of mental illness, substance abuse, and
substance-related problems among all
individuals, including youth. As part of
this effort, SAMHSA has expanded and
refined the agency’s National Registry of
Evidence-based Programs and Practices
(NREPP). Two previous notices
announcing these changes have been
published in the Federal Register (70
FR 165, Aug. 26, 2005, 50381–50390; 71
FR 49, Mar. 14, 2006, 13133–13155).
This notice explains how SAMHSA
and its three Centers will prioritize
interventions submitted for NREPP
reviews during Fiscal Year 2007 and
provides guidance on the submission
process. This information can be helpful
to individuals and organizations seeking
to have an intervention reviewed and
listed on the new NREPP Web site.
For Further Information Contact:
Kevin D. Hennessy, Ph.D., Science to
Service Coordinator/SAMHSA, 1 Choke
Cherry Road, Room 8–1017, Rockville,
MD 20857, (240) 276–2234.
VerDate Aug<31>2005
16:30 Jun 29, 2006
Jkt 208001
Dated: June 26, 2006.
Eric B. Broderick,
Acting Deputy Administrator, SAMHSA,
Assistant Surgeon General.
Substance Abuse and Mental Health
Services Administration’s National
Registry of Evidence-Based Programs
and Practices (NREPP): Priorities for
NREPP Reviews
Background
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) National Registry of
Evidence-Based Programs and Practices
(NREPP) is a voluntary rating and
classification system designed to
provide the public with reliable
information on the scientific basis and
practicality of interventions that prevent
and/or treat mental and substance use
disorders. Descriptive information and
quantitative ratings are provided across
several key areas for all interventions
reviewed by NREPP. This information
will be available to the public through
a new NREPP Web site (https://
www.nrepp.samhsa.gov) scheduled for
launch by the end of 2006.
Public input from a range of
stakeholders has improved NREPP’s
accessibility and usefulness as a
‘‘decision support tool’’ to help States,
Territories, community-based
organizations, and other interested
stakeholders identify interventions that
may meet their needs. NREPP will
provide useful information—including
ratings on the strength of evidence and
readiness for dissemination—to assist
individuals and organizations in
identifying interventions that may
address their particular needs and
match their specific capacities and
resources.
Each of SAMHSA’s Centers—the
Center for Substance Abuse Prevention,
the Center for Substance Abuse
Treatment, and the Center for Mental
Health Services—will establish annual
review priorities regarding the types of
interventions to be included in NREPP.
In general, these priorities will represent
the interests and needs of relevant
stakeholders and reflect SAMHSA’s
matrix and grant priorities.
This notice describes the Centers’
priorities for Fiscal Year 2007 and
provides guidance to individuals and
organizations who may be considering
submitting an intervention for NREPP
review.
SAMHSA defines interventions as
programs, practices, and/or
environmental strategies designed to
change behavioral outcomes among a
definable population or within a
definable geographic area.
The agency anticipates that it will
take a minimum of 3 to 5 years to
expand NREPP to include a broader
array of interventions to prevent and/or
treat mental and/or substance use
disorders.
SAMHSA encourages submissions of
culturally appropriate interventions
targeting specific populations.
Minimum Review Requirements
In order to facilitate the submission of
interventions likely to receive strong
reviews within NREPP, all potential
submissions should provide
documentation that they meet the
following three minimum requirements:
1. The intervention demonstrates one
or more positive changes (outcomes) in
mental health and/or substance use
behavior among individuals,
communities, or populations;
2. Intervention results have been
published in a peer-reviewed
publication or documented in a
comprehensive evaluation report; and
3. Documentation (e.g., manuals,
process guides, tools, training materials)
of the intervention and its proper
implementation is available to the
public to facilitate dissemination.
Submitted interventions that do not
meet all three of these minimum
requirements will not be considered for
potential NREPP review.
Priority Review Points
Submitted interventions meeting the
three minimum requirements will be
prioritized through a system of awarded
points. Interventions will receive one
priority point, and thus higher priority
for potential NREPP review, if they have
been evaluated using a quasiexperimental or experimental study
design. Such studies may include a pre/
post design with comparison or control
group, or longitudinal/time series
design with a minimum of three data
points, one of which must be a baseline
assessment.
One priority point may also be
obtained if the primary outcome(s) of
the submitted intervention is in one or
more of the following areas, categorized
by the Center funding the review:
SAMHSA’s NREPP Priorities
SAMHSA is prioritizing for NREPP
review interventions that prevent and/or
treat mental and/or substance use
disorders. For NREPP purposes,
Center for Substance Abuse Prevention
(CSAP)
CSAP Priority Areas focus on
comprehensive community strategies,
actions and interventions that:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\30JNN1.SGM
30JNN1
]]>Agencies
[Federal Register Volume 71, Number 126 (Friday, June 30, 2006)]
[Notices]
[Pages 37589-37590]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-10286]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer on (240) 276-1243.
Proposed Project: Mandatory Guidelines for Federal Workplace Drug
Testing Programs (OMB No. 0930-0158)--Revision
SAMHSA's Mandatory Guidelines for Federal Workplace Drug Testing
Programs will request OMB approval for the Federal Drug Testing Custody
and Control Form for Federal agency and federally regulated drug
testing programs which must comply with the HHS Mandatory Guidelines
for Federal Workplace Drug Testing Programs (69 FR 19644) dated April
13, 2004, and for the information provided by laboratories for the
National Laboratory Certification Program (NLCP).
The Federal Drug Testing Custody and Control Form is used by all
Federal agencies and employers regulated by the Department of
Transportation to document the collection and chain of custody of urine
specimens at the collection site, for laboratories to report results,
and for Medical Review Officers to make a determination. The Federal
Drug Testing Custody and Control Form approved by OMB three years ago
is being resubmitted for OMB approval without any revision.
Prior to an inspection, a laboratory is required to submit specific
information regarding its laboratory procedures. Collecting this
information prior to an inspection allows the inspectors to thoroughly
review and understand the laboratory(s testing procedures before
arriving at the laboratory.
The NLCP application form has not been revised compared to the
previous form.
The annual total burden estimates for the Federal Drug Testing
Custody and Control Form, the NLCP application, the NLCP inspection
checklist, and NLCP recordkeeping requirements are shown in the
following table.
----------------------------------------------------------------------------------------------------------------
Burden/
Form/respondent response Number of Total annual
(Hrs.) responses burden (Hrs.)
----------------------------------------------------------------------------------------------------------------
Custody and Control Form
Donor....................................................... .08 7,096,000 567,680
Collector................................................... .07 7,096,000 496,720
Laboratory.................................................. .05 7,096,000 354,800
Medical Review Officer...................................... .05 7,096,000 354,800
Laboratory Application.......................................... 3.00 3 9
Laboratory Inspection Checklist................................. 3.00 100 300
Laboratory Recordkeeping........................................ 250.00 50 12,500
-----------------------------------------------
Total....................................................... .............. .............. 1,786,809
----------------------------------------------------------------------------------------------------------------
[[Page 37590]]
Written comments and recommendations concerning the proposed
information collection should be sent by July 31, 2006 to: SAMHSA Desk
Officer, Human Resources and Housing Branch, Office of Management and
Budget, New Executive Office Building, Room 10235, Washington, DC
20503; due to potential delays in OMB's receipt and processing of mail
sent through the U.S. Postal Service, respondents are encouraged to
submit comments by fax to: 202-395-6974.
Dated: June 26, 2006.
Anna Marsh,
Director, Office of Program Services.
[FR Doc. E6-10286 Filed 6-29-06; 8:45 am]
BILLING CODE 4162-20-P
